Journey Colab Overview
- Year Founded
-
2020
- Status
-
Out of Business
- Employees
-
4
- Latest Deal Type
-
Out of Business
Journey Colab General Information
Description
Operator of a therapeutics and clinical application company intended to build a model of addiction care by leveraging the potential of new psychedelic therapeutics. The company uses the compound synthetic mescaline hydrochloride for patients with alcohol-use disorder, enabling medical professionals to offer healing support and medication for mental illnesses.
Contact Information
Website
www.journeycolab.comCorporate Office
- 548 Market Street
- Suite 85082
- San Francisco, CA 94104
- United States
Corporate Office
- 548 Market Street
- Suite 85082
- San Francisco, CA 94104
- United States
Journey Colab Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Out of Business | 06-Jan-2025 | Completed | Out of Business | |||
| 3. Early Stage VC | 17-Aug-2022 | Completed | Pre-Clinical Trials | |||
| 2. Early Stage VC (Series A) | 01-Nov-2021 | $15.7M | $18.7M | Completed | Pre-Clinical Trials | |
| 1. Early Stage VC (Series A) | 26-Oct-2020 | $3M | $3M | Completed | Startup |
Journey Colab Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A2 | ||||||||
| Series A1 | ||||||||
| Series A | 1,754,488 | $0.000010 | $1.71 | $1.71 | 1x | $1.71 | 11.25% |
Journey Colab Patents
Journey Colab Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20250162980-A1 | Methods for preparing mescaline | Pending | 25-Feb-2022 | ||
| WO-2023164178-A2 | Methods for preparing mescaline | Inactive | 25-Feb-2022 | ||
| WO-2023164178-A3 | Methods for preparing mescaline | Inactive | 25-Feb-2022 | ||
| US-20250064782-A1 | Methods of treating substance use disorders using 5-meo-dmt | Pending | 17-Dec-2021 | ||
| WO-2023114557-A2 | Methods of treating substance use disorders using 5-meo-dmt | Inactive | 17-Dec-2021 | A61K31/4045 |
Journey Colab Signals
Journey Colab FAQs
-
When was Journey Colab founded?
Journey Colab was founded in 2020.
-
Where is Journey Colab headquartered?
Journey Colab is headquartered in San Francisco, CA.
-
What is the size of Journey Colab?
Journey Colab has 4 total employees.
-
What industry is Journey Colab in?
Journey Colab’s primary industry is Drug Discovery.
-
Is Journey Colab a private or public company?
Journey Colab is a Private company.
-
What is Journey Colab’s current revenue?
The current revenue for Journey Colab is .
-
How much funding has Journey Colab raised over time?
Journey Colab has raised $30.7M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process